Valuation: Terumo Corporation

Market Cap 3,799B 23.85B 20.67B 19.35B 17.66B 33.23B 2,275B 33.79B 227B 88.9B 1,139B 89.56B 87.61B P/E 2027 *
20.5x
P/E 2028 * 20x
Enterprise Value 3,865B 24.27B 21.03B 19.69B 17.96B 33.8B 2,314B 34.37B 231B 90.44B 1,158B 91.11B 89.12B EV / Sales 2027 *
3.09x
EV / Sales 2028 * 2.81x
Free-Float
97.07%
Yield 2027 *
1.43%
Yield 2028 * 1.57%
1 day+0.89%
1 week+13.57%
Current month+11.81%
1 month+17.39%
3 months+35.23%
6 months+25.53%
Current year+14.47%
1 week 2,280
Extreme 2280
2,625.5
1 month 2,133
Extreme 2133
2,625.5
Current year 1,900
Extreme 1900
2,625.5
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+13.57%-4.69%+22.43% 23.85B
+1.01%+4.04%-16.47%+4.19% 190B
+1.42%+5.20%-2.22%+8.66% 116B
+2.73%+9.01%+14.85%+78.19% 63.71B
-0.91%+0.42%+31.56%+61.20% 55.13B
+0.99%+6.64%-5.76%-35.74% 49.41B
+2.14%+2.98%+15.00%-19.84% 33.79B
+3.64%-16.65% - - 30.74B
-0.22%+0.75%+46.20%-10.99% 24.73B
-0.28%+2.31%-1.40%+4.49% 23.23B
Average +1.14%+3.00%+8.56%+12.51% 61.05B
Weighted average by Cap. +1.18%+3.98%+0.90%+13.95%

Financials

2027 *2028 *
Net sales 1,251B 7.86B 6.81B 6.37B 5.81B 10.94B 749B 11.13B 74.73B 29.28B 375B 29.49B 28.85B 1,331B 8.36B 7.24B 6.78B 6.19B 11.64B 797B 11.84B 79.51B 31.15B 399B 31.38B 30.7B
Net income 183B 1.15B 994M 931M 849M 1.6B 109B 1.63B 10.91B 4.28B 54.78B 4.31B 4.21B 190B 1.19B 1.03B 965M 881M 1.66B 113B 1.69B 11.32B 4.43B 56.8B 4.47B 4.37B
Net Debt 65.54B 412M 357M 334M 305M 573M 39.25B 583M 3.91B 1.53B 19.65B 1.55B 1.51B -62.96B -395M -343M -321M -293M -551M -37.71B -560M -3.76B -1.47B -18.87B -1.48B -1.45B
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
12/08/26 ¥2,598.50 +0.89% 6,704,400
10/08/26 ¥2,575.50 +8.53% 8,398,500
07/08/26 ¥2,373.00 +2.64% 4,340,100
06/08/26 ¥2,312.00 +1.05% 4,737,000
05/08/26 ¥2,288.00 -1.51% 4,036,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,575.50JPY
Average target price
3,075.38JPY
Spread / Average Target
+19.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock